Alopecia Risk With GLP ‐1 Receptor Agonists: A Disproportionality Analysis Using the FDA Adverse Event Reporting System ( FAERS )

Alopecia Risk With GLP ‐1 Receptor Agonists: A Disproportionality Analysis Using the FDA Adverse Event Reporting System ( FAERS ) | ReachRx